Atara Biotherapeutics (ATRA) Interest Coverage Ratio (2022 - 2026)
Atara Biotherapeutics (ATRA) reported Interest Coverage Ratio of 4.06 for Q1 2026, down 110.64% on a YoY basis from 38.15 in Q1 2025, and up 88.5% quarter-over-quarter from 35.3 in Q4 2025.
Atara Biotherapeutics (ATRA) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Atara Biotherapeutics has reported Interest Coverage Ratio for 5 years, with the latest figure at 4.06 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 110.64% year-over-year to 4.06; the trailing twelve-month figure through Mar 2026 stood at 9.79 (down 227.57% YoY), and the FY2025 full-year result was 1.81, up 110.02% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 4.06, up from 35.3 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 38.15 in Q1 2025, with the low at 22055.0 in Q1 2022.
- Historically, Interest Coverage Ratio has averaged 1407.08 across 5 years, with a median of 35.3 in 2025.
- The largest YoY upside for Interest Coverage Ratio was 240.78% in 2025 against a maximum downside of 194.15% in 2025.
- Atara Biotherapeutics' Interest Coverage Ratio stood at 645.63 in 2022, then soared by 92.1% to 50.99 in 2023, then soared by 76.47% to 12.0 in 2024, then tumbled by 194.15% to 35.3 in 2025, then jumped by 88.5% to 4.06 in 2026.
- The last three Interest Coverage Ratio figures came in at 4.06 (Q1 2026), 35.3 (Q4 2025), and 3.93 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 | -4.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.06 |
| Dec 31, 2025 | -35.30 |
| Sep 30, 2025 | -3.93 |
| Jun 30, 2025 | 3.29 |
| Mar 31, 2025 | 38.15 |
| Dec 31, 2024 | -12.00 |
| Sep 30, 2024 | -18.39 |
| Jun 30, 2024 | -14.45 |
| Mar 31, 2024 | -27.10 |
| Dec 31, 2023 | -50.99 |
| Sep 30, 2023 | -49.90 |
| Jun 30, 2023 | -51.82 |
| Mar 31, 2023 | -56.15 |
| Dec 31, 2022 | -645.63 |
| Sep 30, 2022 | -687.98 |
| Jun 30, 2022 | -249.09 |
| Mar 31, 2022 | -22,055.00 |